Global and Europe Biologics and Biosimilars Market Status and Future Forecast 2013-2023

January 2018 | 156 pages | ID: G628FDE5558EN
99Strategy

Abstracts

Summary

Key Content of Chapters (Including and can be customized)

Part 1: Market Overview, Development, and Segment by Type, Application & Region
Part 2: Global Market by company, Type, Application & Region
Part 3: Europe Market by company, Type, Application
Part 4-13: Key Regions of Europe Market by Type, Application
Part 14: Company information, Sales, Cost, Margin etc.
Part 15: Conclusion

Market Segment as follows:

By Region

• Global (Europe, America, Asia etc.)
• Europe (Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland, etc.)

Key Companies

• Roche
• Amgen
• AbbVie
• Sanofi-Aventis
• Johnson & Johnson
• Pfizer
• Novo Nordisk
• Eli Lilly
• Novartis
• Merck
• 3sbio
• Changchun High Tech
• CP Guojian
• Biotech
• Gelgen
• Innovent
• Dong Bao
• Ganlee
• United Laboratories

Market by Type

• Antibody
• Hormone
• Growth Factors
• Others

Market by Application

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Others

Contents

Table of Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 EUROPE MARKET STATUS AND FUTURE FORECAST

3.1 Europe Market by Region
3.2 Europe Market by Company
3.3 Europe Market by Type
3.4 Europe Market by Application
3.5 Europe Market by Forecast

PART 4 GERMANY MARKET STATUS AND FUTURE FORECAST

4.1 Germany Market by Type
4.2 Germany Market by Application
4.3 Germany Market by Forecast

PART 5 UK MARKET STATUS AND FUTURE FORECAST

5.1 UK Market by Type
5.2 UK Market by Application
5.3 UK Market by Forecast

PART 6 FRANCE MARKET STATUS AND FUTURE FORECAST

6.1 France Market by Type
6.2 France Market by Application
6.3 France Market by Forecast

PART 7 ITALY MARKET STATUS AND FUTURE FORECAST

7.1 Italy Market by Type
7.2 Italy Market by Application
7.3 Italy Market by Forecast

PART 8 RUSSIA MARKET STATUS AND FUTURE FORECAST

8.1 Russia Market by Type
8.2 Russia Market by Application
8.3 Russia Market by Forecast

PART 9 SPAIN MARKET STATUS AND FUTURE FORECAST

9.1 Spain Market by Type
9.2 Spain Market by Application
9.3 Spain Market by Forecast

PART 10 NETHERLANDS MARKET STATUS AND FUTURE FORECAST

10.1 Netherlands Market by Type
10.2 Netherlands Market by Application
10.3 Netherlands Market by Forecast

PART 11 TURKEY MARKET STATUS AND FUTURE FORECAST

11.1 Turkey Market by Type
11.2 Turkey Market by Application
11.3 Turkey Market by Forecast

PART 12 SWITZERLAND MARKET STATUS AND FUTURE FORECAST

12.1 Switzerland Market by Type
12.2 Switzerland Market by Application
12.3 Switzerland Market by Forecast

PART 13 OTHER REGIONS OF EUROPE MARKET STATUS AND FUTURE FORECAST

13.1 Other Regions of Europe Market by Type
13.2 Other Regions of Europe Market by Application
13.3 Other Regions of Europe Market by Forecast

PART 14 KEY COMPANIES

14.1 Roche
14.2 Amgen
14.3 AbbVie
14.4 Sanofi-Aventis
14.5 Johnson & Johnson
14.6 Pfizer
14.7 Novo Nordisk
14.8 Eli Lilly
14.9 Novartis
14.10 Merck
14.11 3sbio
14.12 Changchun High Tech
14.13 CP Guojian
14.14 Biotech
14.15 Gelgen
14.16 Innovent
14.17 Dong Bao
14.18 Ganlee
14.19 United Laboratories

PART 15 CONCLUSION

List Of Tables

LIST OF TABLES

Table TYPE OF BIOLOGICS AND BIOSIMILARS
Table Application of Biologics and Biosimilars
Table Global Biologics and Biosimilars Market by Region, 2013-2017 (Million USD)
Table Global Biologics and Biosimilars Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Biologics and Biosimilars Market by Company, 2013-2017 (Million USD)
Table Global Biologics and Biosimilars Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table Global Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table Global Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Europe Biologics and Biosimilars Market by Region, 2013-2017 (Million USD)
Table Europe Biologics and Biosimilars Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Europe Biologics and Biosimilars Market by Company, 2013-2017 (Million USD)
Table Europe Biologics and Biosimilars Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Europe Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table Europe Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Europe Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table Europe Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Germany Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table Germany Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Germany Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table Germany Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table UK Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table UK Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table UK Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table UK Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table France Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table France Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table France Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table France Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Italy Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table Italy Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Italy Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table Italy Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Russia Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table Russia Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Russia Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table Russia Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Spain Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table Spain Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Spain Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table Spain Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Other Regions of Europe Biologics and Biosimilars Market by Type, 2013-2017 (Million USD)
Table Other Regions of Europe Biologics and Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Other Regions of Europe Biologics and Biosimilars Market by Application, 2013-2017 (Million USD)
Table Other Regions of Europe Biologics and Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Roche Information
Table Biologics and Biosimilars Sales, Cost, Margin of Roche
Table Amgen Information
Table Biologics and Biosimilars Sales, Cost, Margin of Amgen
Table AbbVie Information
Table Biologics and Biosimilars Sales, Cost, Margin of AbbVie
Table Sanofi-Aventis Information
Table Biologics and Biosimilars Sales, Cost, Margin of Sanofi-Aventis
Table Johnson & Johnson Information
Table Biologics and Biosimilars Sales, Cost, Margin of Johnson & Johnson
Table Pfizer Information
Table Biologics and Biosimilars Sales, Cost, Margin of Pfizer
Table Novo Nordisk Information
Table Biologics and Biosimilars Sales, Cost, Margin of Novo Nordisk
Table Eli Lilly Information
Table Biologics and Biosimilars Sales, Cost, Margin of Eli Lilly
Table Novartis Information
Table Biologics and Biosimilars Sales, Cost, Margin of Novartis
Table Merck Information
Table Biologics and Biosimilars Sales, Cost, Margin of Merck
Table 3sbio Information
Table Biologics and Biosimilars Sales, Cost, Margin of 3sbio
Table Changchun High Tech Information
Table Biologics and Biosimilars Sales, Cost, Margin of Changchun High Tech
Table CP Guojian Information
Table Biologics and Biosimilars Sales, Cost, Margin of CP Guojian
Table Biotech Information
Table Biologics and Biosimilars Sales, Cost, Margin of Biotech
Table Gelgen Information
Table Biologics and Biosimilars Sales, Cost, Margin of Gelgen
Table Innovent Information
Table Biologics and Biosimilars Sales, Cost, Margin of Innovent
Table Dong Bao Information
Table Biologics and Biosimilars Sales, Cost, Margin of Dong Bao
Table Ganlee Information
Table Biologics and Biosimilars Sales, Cost, Margin of Ganlee
Table United Laboratories Information
Table Biologics and Biosimilars Sales, Cost, Margin of United Laboratories

List Of Figures

LIST OF FIGURES

Figure Global Biologics and Biosimilars Market Share by Application in 2018
Figure Global Biologics and Biosimilars Market Share by Region in 2018
Figure Europe Biologics and Biosimilars Market Share by Region in 2018
Figure Global Biologics and Biosimilars Market Share by Region in 2017 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Region in 2017 (Volume)
Figure Global Biologics and Biosimilars Market Share by Company in 2017 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2017 (Volume)
Figure Germany Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure Germany Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure Germany Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure UK Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure UK Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure UK Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure UK Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure UK Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure France Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure France Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure France Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure France Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure France Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Italy Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure Italy Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure Italy Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure Italy Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure Italy Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Russia Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure Russia Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure Russia Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure Russia Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure Russia Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Spain Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure Spain Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure Spain Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure Spain Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure Spain Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Netherlands Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure Netherlands Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Turkey Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure Turkey Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure Turkey Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure Turkey Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure Turkey Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Switzerland Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure Switzerland Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Other Regions of Europe Biologics and Biosimilars Market Share by Type in 2017 (Million USD)
Figure Other Regions of Europe Biologics and Biosimilars Market Share by Type in 2017 (Volume)
Figure Other Regions of Europe Biologics and Biosimilars Market Share by Application in 2017 (Million USD)
Figure Other Regions of Europe Biologics and Biosimilars Market Share by Application in 2017 (Volume)
Figure Other Regions of Europe Biologics and Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Other Regions of Europe Biologics and Biosimilars Market Forecast, 2018-2023 (Volume)